Your browser doesn't support javascript.
loading
Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma.
Shi, WeiKang; Jin, Lu; Xu, AiHua; Gao, Yu; Zhang, Na.
Afiliación
  • Shi W; Department of Dermatology, Jinhua Maternal and Child Health Care Hospital, Jinhua, Zhejiang Province, People's Republic of China.
  • Jin L; Department of Nursing, Jinhua Central Hospital, Jinhua, Zhejiang Province, People's Republic of China.
  • Xu A; Department of Nursing, Jinhua Central Hospital, Jinhua, Zhejiang Province, People's Republic of China.
  • Gao Y; Department of Dermatology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People's Republic of China.
  • Zhang N; Department of Dermatology, Jinhua Central Hospital, Jinhua, Zhejiang Province, People's Republic of China.
Clin Cosmet Investig Dermatol ; 17: 2009-2019, 2024.
Article en En | MEDLINE | ID: mdl-39253065
ABSTRACT

Purpose:

Superficial Infantile hemangioma (SIH) is the most common type of IH. Some studies have shown the efficacy of 755-nm long pulse alexandrite laser (LPAL) and topical 2% carteolol hydrochloride (C-HCL) eye drops for the treatment of SIH. This article retrospectively analyzes the safety and efficacy of 755-nm LPAL combined with 2% C-HCL eye drops for treating thicker SIH, and explores the optimal treatment time for SIH. Materials and

Methods:

This study included 2-5 mm thick SIH patients who received co-treatment of 755-nm LPAL and 2% C-HCL eye drops. The SIH patients were divided into 3 groups based on their age and IH growth curve ≤ 1 month (≤ 1M), 1-3 months (excluding 1 month; 1-3M), and 3-12 months (excluding 3 months; 3-12M).

Results:

There was no difference in efficacy between the ≤ 1M and the 1-3M group, and were both better than the 3-12M group. Furthermore, there was no difference in the average number of treatments between the ≤ 1M and 1-3M groups and were both less than the 3-12M group. There was no significant difference in the incidence of adverse reactions between the groups. Compared with the ≤ 1M and 1-3M groups, the 3-12M group indicated more permanent skin lesions after the treatment.

Conclusion:

It was revealed that co-treatment with 755-nm LPAL and 2% C-HCL eye drops is safe and effective against thicker SIH. Compared with the 3-12M group, ≤ 3 months can achieve better efficacy, requires a shorter treatment time, less likely to leave permanent skin lesions such as scars. Moreover, patients with no proliferation can be observed to 1 month.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Cosmet Investig Dermatol Año: 2024 Tipo del documento: Article Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Cosmet Investig Dermatol Año: 2024 Tipo del documento: Article Pais de publicación: Nueva Zelanda